Wellcome-MRC Cambridge Stem Cell Institute
Davide Rossetti earned his degree in Biotechnology at the University of Perugia, in 2020. He worked in the research institute Mario Negri in Milan, where he approached PROTAC chemistry applications. He was awarded a MSc in Pharmaceutical Biotechnology from the University of Bologna in 2023 working on Ischemic Cholangiopathy. He has kept working on cholangiopaties and he is a prospective PhD student at CRUK .
Brevini, T. (2023). FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2. Nature. (https://www.nature.com/articles/s41586-022-05594-0)
Contact us
Jeffrey Cheah Biomedical Centre
Puddicombe Way
Cambridge Biomedical Campus
CB2 0AW
© 2024 University of Cambridge